Bayesian vs Frequentist A/B Testing — A Practical Comparison

Your dashboard shows a frequentist p-value of 0.04 and a Bayesian probability that variant B beats control of 96%. The product manager asks: "So we ship?" The honest answer depends on which question you are trying to answer — and those two numbers are not interchangeable.

Frequentist and Bayesian A/B testing are not rival religions. They are two frameworks for turning noisy experiment data into decisions. This guide explains what each one actually computes, where they disagree on peeking and stopping, how priors and intervals differ, and when each approach earns its place on your team.

What the frequentist framework asks

In the standard frequentist A/B test, you assume the null hypothesis: there is no difference between control and variant. You collect data, compute a test statistic, and derive a p-value — the probability of seeing data at least this extreme if the true effect were exactly zero.

The p-value does not tell you the probability that B is better. It tells you how awkward "no effect" looks as an explanation. Significance is a gate: if \( p < \alpha \) and you followed your pre-registered plan, you reject the null. For a deeper walkthrough of what that means — and what it does not — see our p-value guide.

Frequentist inference is built around long-run error control. If you run many experiments at \( \alpha = 0.05 \), about 5% of null experiments will look significant by chance — provided you stick to the rules you set before collecting data.

What the Bayesian framework asks

Bayesian A/B testing flips the question. Instead of asking "how surprising is this data if there is no effect?", it asks: "given the data we observed, what is the probability that variant B is better than control?"

The output is often a posterior probability ("92% chance B wins") and a credible interval — a range that, under the model, contains the true effect with a stated probability. That language maps more directly to how product teams think: "How likely is it that this change helps?"

Peeking, stopping, and why they diverge

This is where the frameworks feel most different in day-to-day practice. Frequentist tests assume a fixed sample size or a pre-specified sequential design. Check the p-value every morning and stop when it crosses 0.05 — peeking — and your false positive rate balloons far above \( \alpha \). We cover the mechanics in our test duration guide; the short version is: unplanned early stopping invalidates the p-value.

Frequentist options for early stopping

• Fixed horizon — run to the sample size you calculated upfront. Safest, simplest.
• Group sequential / SPRT — pre-specify interim looks with adjusted boundaries so overall error rate stays controlled.
• Always-Valid inference (mSPRT) — methods that allow continuous monitoring with valid p-values at any time.

Bayesian peeking

Bayesian updating is coherent at any sample size: each new user updates the posterior. There is no "invalid peeking" in the same sense — you are always reporting \( P(\text{B better} \mid \text{all data so far}) \). That flexibility is attractive for teams that want live dashboards.

Priors: the Bayesian knob frequentists do not have

Every Bayesian analysis starts with a prior — your belief about the effect before seeing data. A weak prior (wide, centered near zero) lets the data dominate. A strong prior can pull small-sample results toward "probably no big effect" — useful when large lifts are historically rare in your product.

• Informative priors encode domain knowledge (e.g., "UI copy changes rarely move conversion more than 2%").
• Skeptical priors shrink noisy early estimates — helpful when peeking at small samples.
• Flat priors are easy to defend but can behave badly with very low conversion rates.

The prior is not a weakness — it is an explicit assumption. Frequentist methods embed similar assumptions (choice of test, alpha, MDE) but hide them in the design rather than the math output.

Credible intervals vs confidence intervals

These look identical on a chart but mean different things:

• 95% confidence interval (frequentist): a procedure that, in repeated experiments, covers the true effect 95% of the time. For this one experiment, the interval either contains the truth or it does not — no probability attached.
• 95% credible interval (Bayesian): under the posterior, there is a 95% probability the true effect lies in this range.

For product decisions, the Bayesian wording often clicks faster: "We are 95% sure the lift is between +0.3% and +1.8%." The frequentist interval carries the same practical information for go/no-go if you treat it as "effects outside this range are hard to reconcile with the data." See our confidence interval guide for the frequentist side in depth.

When to prefer which

Neither framework is universally superior. Match the tool to the decision:

• Prefer frequentist when you need strict error control for a fixed decision, regulatory-style documentation, or alignment with a pre-registered sample size and single end-of-test readout.
• Prefer Bayesian when you want continuous monitoring, direct "probability B wins" language, or forecast-style decisions that weight uncertainty explicitly.
• Use both as sanity checks when stakes are high — if a frequentist CI barely excludes zero but the posterior says 99% B wins, investigate (priors, model mismatch, SRM) before shipping.

AB-Labz Workbench supports both lenses: frequentist analysis with confidence intervals and p-values, plus a Bayesian forecast view that tracks posterior win probability as data accumulates — useful when you need live reads without abandoning rigor.

Summary

Frequentist A/B testing asks how surprising your data is under "no effect" and controls false positives over many experiments — if you respect stopping rules. Bayesian A/B testing asks how likely each variant is to be better given the data (and your prior), and handles continuous updating naturally. Credible and confidence intervals answer different philosophical questions but both help you judge magnitude. Pick the framework that matches how your team decides, document it upfront, and do not treat a p-value and a posterior probability as the same answer.